Sinovac Biotech Ltd.
39 Shangdi Xi Road
Haidian District
Beijing,
100085
China - Map
Phone: 86 10 8289 0088
Fax: 86 10 6296 6910
Web Site: http://www.sinovac.com
| Sinovac Biotech Ltd., a biopharmaceutical company, focuses on the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases in China. Its portfolio of regulatory-approved products consists of vaccines against the hepatitis A, hepatitis B and influenza viruses. The company offers Healive, an inactivated hepatitis A vaccine; Bilive, a combination hepatitis A and B vaccine; Anflu, a split virus influenza vaccine; and Panflu, a vaccine against the H5N1 influenza virus. The companys pipeline vaccine candidates in the pre-clinical and clinical development phases include human vaccines for Enterovirus 71, Japanese encephalitis virus, and rabies; a vaccine for the SARS virus, which completed Phase I clinical trial; animal rabies vaccine; and a split viron vaccine for the H5N1 influenza virus, which completed Phase II clinical trial. It markets and sells its vaccine products primarily through various provincial and municipal centers for disease control and prevention. Sinovac Biotech Ltd. was founded in 1999 and is headquartered in Beijing, the Peoples Republic of China. |
|
| Key Statistics |
| |
| | Pay | Exercised | Prof. Pan Aihua ,
Chairman |
N/A
| N/A | Mr. Weidong Yin , 44
Chairman, Chief Exec. Officer, Pres, Sec., Gen. Mang. of Sinovac Biotech Co of Sinovac Biotech Co |
N/A
| N/A | Ms. Jinling Qin , 64
Acting Chief Financial Officer |
N/A
| N/A | Ms. Zou Bin , 39
Treasurer and Accounting Mang. of Sinovac Biotech Co Ltd |
N/A
| N/A | Ms. Nan Wang , 43
Vice Gen. Mang. of Sinovac Beijing |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-06
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.29% Nasdaq 0.00%
Profile
